Profile photo Nadia Haj Mohammad

Nadia Haj Mohammad

Assistant Professor - medical

Strategic program(s):

Biography

Dr. N. Haj Mohammad (1976) has been working as a medical oncologist in the UMC Utrecht since 2014. She studied pharmacy in the same city, and completed her pharmacy training in 2001. One year earlier, she started Medical school at the University of Amsterdam. She combined her training as a medical-oncologist at the AMC with PhD research in the clinical outcomes of treatments for gastroesophageal and pancreatic carcinoma.

She is member of the national guidelines for hepatocellular carcinoma and bile duct carcinoma. She is a board member of the Dutch Upper GI Cancer group.

Her research focuses on clinical outcomes of gastroesophageal and primary liver cancers. She is national PI of the phase 2 LyRICX study in metastatic gastroesophageal cancer and is local PI of multiple investigator and sponsor investigated studies within tumors of the upper digestive tract and primary liver tumors.

Strategic program(s):

Contact

Research groups

Primary Liver Tumors research group

Research aim

To improve surveillance, diagnostics, treatment, and outcome for patients with primary liver tumors (hepatocellular carcinoma and cholangiocarcinoma) by interdisciplinary and (inter-)national collaborative research

Go to group

Recent publications

Association between effectiveness of treatment with curative intent and outcomes of first-line systemic therapy in metachronous metastatic gastroesophageal adenocarcinoma D Kamp, A M May, M J M van Velzen, S Mook, J E Freund, B Mostert, R H A Verhoeven, H W M van Laarhoven, N Haj Mohammad
British Journal of Cancer, 2026, vol. 134, p.1420-1428
Effects of exercise and diet in patients with incurable gastroesophageal cancer Aniek Bonhof, Anouk E Hiensch, Nicolette J Wierdsma, Linde F Huis In 't Veld, Sandra D Bakker, Aart Beeker, Marjan Davidis-van Schoonhoven, Helga Droogendijk, Jan C Drooger, Joeri A J Douma, Ruben S A Goedegebuure, Nadia Haj Mohammad, Irene E G van Hellemond, Karin Herbschleb, Johan J B Janssen, Bianca Mostert, Marije Slingerland, Dirkje Sommeijer, Liesbeth Timmermans, Arjan J Verschoor, Vincent A de Weger, Harm Westdorp, Miriam L Wumkes, Anne M May, Hanneke W M van Laarhoven
JNCI cancer spectrum, 2026, vol. 10
Patient-derived cancer organoids to tailor personalized treatment strategies in upper gastrointestinal malignancies Ingrid A Franken, Georg Busslinger, Bas L A M Weusten, Lodewijk A A Brosens, Jelle P Ruurda, Nadia Haj Mohammad, Stella Mook, Hans Clevers, Richard Van Hillegersberg
Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus, 2026, vol. 39
Adjuvant nivolumab after chemoradiotherapy and resection for patients with esophageal cancer Rob H A Verhoeven, Steven C Kuijper, Marije Slingerland, Bas Wijnhoven, Mark I van Berge Henegouwen, Peter S N van Rossum, Sarah Derks, Bianca Mostert, Nadia Haj Mohammad, Hanneke W M van Laarhoven
International Journal of Cancer, 2025, vol. 158, p.1292-1301
A Novel TRG-N Prognostic Classification System for Esophageal Cancer Undergoing Neoadjuvant Therapy Followed by Esophagectomy Jingpu Wang, Zhouqiao Wu, Rob H A Verhoeven, Lucas Goense, Nadia Haj Mohammad, Stella Mook, Peter S N van Rossum, Marije Slingerland, Jan Erik Freund, Jelle P Ruurda, Richard van Hillegersberg
Annals of surgery, 2025, vol. 282, p.837-44
Impact of endoscopic ultrasonography with fine needle aspiration assessing clinical lymph node staging on radiotherapy treatment planning in esophageal cancer patients R B den Boer, M E Sanders, G J Meijer, N Haj Mohammad, M A M T Verhagen, J E Freund, L A A Brosens, B L A M Weusten, P Friederich, L Alvarez Herrero, J P Ruurda, R van Hillegersberg, S Mook
Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus, 2025, vol. 38